Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites.
<h4>Background</h4>A malaria vaccine could be an important addition to current control strategies. We report the safety and vaccine efficacy (VE) of the RTS,S/AS01 vaccine during 18 mo following vaccination at 11 African sites with varying malaria transmission.<h4>Methods and findi...
Guardado en:
Autor principal: | RTS,S Clinical Trials Partnership |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/09d7679c0bf84b1893a6c44f6322e42f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children.
por: Daniel Ansong, et al.
Publicado: (2011) -
RTS,S Malaria Vaccine and Increased Mortality in Girls
por: Sabra L. Klein, et al.
Publicado: (2016) -
Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy
por: Carlota Dobaño, et al.
Publicado: (2019) -
Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
por: Mark E Polhemus, et al.
Publicado: (2009) -
Insights from modelling malaria vaccines for policy decisions: the focus on RTS,S
por: Katya Galactionova, et al.
Publicado: (2021)